Dr. Sameer Thapar (Assistant Professor and Advisor, Drug Safety Pharmacovigilance, MS Clinical Trial Sciences Program, Biomedical Health Sciences, Rutgers University) and graduate student Katelin Tonner-Ingram discuss the challenges faced by manufacturers regarding adverse event reporting, a recent shift in who is actually reporting adverse events, and the role of specialty pharmacies in risk management.  To learn more about adverse event reporting and risk management, plan to attend the DIA Pharmacovigilance and Risk Management Strategies 2016 conference.